Clinical Trial Update: Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of chemotherapy, donor stem cell transplant, tacrolimus, mycophenolate mofetil, and cyclophosphamide in hematolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-05-03